Skip to main content
. 2018 Nov 21;115(50):E11701–E11710. doi: 10.1073/pnas.1804506115

Table 1.

Number of eQTLs and eGenes per cancer type

Cancer type Acronym Sample size eQTL count eGene count
Adrenocortical carcinoma ACC 49 5 5
Bladder urothelial carcinoma BLCA 151 958 808
Breast invasive carcinoma BRCA 799 14,089 8,474
Cervical squamous cell carcinoma and endocervical adenocarcinoma CESC 118 698 604
Colon adenocarcinoma COAD 183 3,351 2,510
Glioblastoma multiforme GBM 135 2,295 1,776
Head and neck squamous cell carcinoma HNSC 364 6,361 4,314
Kidney renal clear cell carcinoma KIRC 61 239 228
Kidney renal papillary cell carcinoma KIRP 102 1,085 940
Acute myeloid leukemia LAML 122 2,714 2,118
Brain lower grade glioma LGG 255 8,273 5,531
Liver hepatocellular carcinoma LIHC 85 328 298
Lung adenocarcinoma LUAD 361 6,545 4,265
Lung squamous cell carcinoma LUSC 264 3,349 2,313
Ovarian serous cystadenocarcinoma OV 318 3,882 2,656
Pancreatic adenocarcinoma PAAD 46 74 73
Prostate adenocarcinoma PRAD 209 8,166 5,628
Rectum adenocarcinoma READ 73 391 355
Sarcoma SARC 90 308 277
Skin cutaneous melanoma SKCM 73 155 144
Stomach adenocarcinoma STAD 234 2,710 1,933
Thyroid carcinoma THCA 366 16,737 10,153
Uterine corpus endometrial carcinoma UCEC 336 4,315 3,050
Uterine carcinosarcoma UCS 46 8 8